| Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis RF Franco, PH Reitsma, D Lourenco, FH Maffei, V Morelli, MH Tavella, ... Thrombosis and haemostasis 81 (05), 676-679, 1999 | 204 | 1999 |
| ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden VM Morelli, MCH De Visser, HL Vos, RM Bertina, FR Rosendaal Journal of thrombosis and haemostasis 3 (1), 183-185, 2005 | 172 | 2005 |
| Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis RF Franco, MG Fagundes, JC Meijers, PH Reitsma, D Lourenço, V Morelli, ... haematologica 86 (5), 510-517, 2001 | 160 | 2001 |
| The role of IL-6, IL-8 and MCP-1 and their promoter polymorphisms IL-6-174GC, IL-8-251AT and MCP-1-2518AG in the risk of venous thromboembolism: a case-control study MF Matos, DM Lourenço, CM Orikaza, JAH Bajerl, MAE Noguti, ... Thrombosis research 128 (3), 216-220, 2011 | 92 | 2011 |
| ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens VM Morelli, MCH de Visser, NH van Tilburg, HL Vos, JCJ Eikenboom, ... Thrombosis and haemostasis 97 (04), 534-541, 2007 | 90 | 2007 |
| Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients VM Morelli, DM Lourenço, V D'almeida, RF Franco, F Miranda, MA Zago, ... Blood coagulation & fibrinolysis 13 (3), 271-275, 2002 | 67 | 2002 |
| Tuberculosis: an uncommon cause of cerebral venous thrombosis? JA Fiorot Júnior, AC Felício, MM Fukujima, CA Rodrigues, VM Morelli, ... Arquivos de neuro-psiquiatria 63, 852-854, 2005 | 59 | 2005 |
| A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease RF Franco, V Morelli, D Lourenco, FH Maffei, MH Tavella, CE Piccinato, ... British journal of haematology 105 (2), 556-559, 1999 | 54 | 1999 |
| Lipid levels and risk of venous thrombosis: results from the MEGA-study VM Morelli, WM Lijfering, MHA Bos, FR Rosendaal, SC Cannegieter European journal of epidemiology 32, 669-681, 2017 | 52 | 2017 |
| The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease F Moreira Neto, DM Lourenco, MAE Noguti, VM Morelli, ICP Gil, ... Brazilian journal of medical and biological research 39, 1291-1295, 2006 | 46 | 2006 |
| Factor V Arg306 → Thr (factor V Cambridge) and factor V Arg306 → Gly mutations in venous thrombotic disease Franco, Maffei, LourenÇo, Morelli, Thomazini, Piccinato, Tavella, Zago British journal of haematology 103 (3), 888-890, 1998 | 45 | 1998 |
| Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism MS Edvardsen, K Hindberg, ES Hansen, VM Morelli, T Ueland, P Aukrust, ... Blood advances 5 (1), 224-232, 2021 | 39 | 2021 |
| Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients CA Rodrigues, LKA Rocha, VM Morelli, RF Franco, DM Lourenco Journal of Thrombosis and Haemostasis 2 (7), 1211-1212, 2004 | 37 | 2004 |
| Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism T Frischmuth, K Hindberg, P Aukrust, T Ueland, SK Brækkan, JB Hansen, ... Journal of Thrombosis and Haemostasis 20 (7), 1618-1626, 2022 | 35 | 2022 |
| Cross-ancestry investigation of venous thromboembolism genomic predictors F Thibord, D Klarin, JA Brody, MH Chen, MG Levin, DI Chasman, ... Circulation 146 (16), 1225-1242, 2022 | 34 | 2022 |
| Development and implementation of common data elements for venous thromboembolism research: on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH G Le Gal, M Carrier, LA Castellucci, A Cuker, JB Hansen, FA Klok, ... Journal of Thrombosis and Haemostasis 19 (1), 297-303, 2021 | 32 | 2021 |
| Role of microRNAs in venous thromboembolism VM Morelli, SK Brækkan, JB Hansen International Journal of Molecular Sciences 21 (7), 2602, 2020 | 30 | 2020 |
| Avaliação clínica e laboratorial de pacientes em uso de anticoagulantes orais DM Lourenço, LHC Lopes, CV Vignal, VM Morelli Arq Bras Cardiol 68 (5), 353-6, 1997 | 30 | 1997 |
| The frequency of 844ins68 mutation in the cystathionine β-synthase gene is not increased in patients with venous thrombosis R Franco, FHA Maffei, D Lourenço, C Piccinato, V Morelli, I Thomazini, ... Haematologica, 1006-1008, 1998 | 29 | 1998 |
| Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY) F Pieroni, DM Lourenço, VM Morelli, FH Maffei, MA Zago, RF Franco Thrombosis research 120 (2), 221-229, 2007 | 28 | 2007 |
